Genetic background of esophageal squamous cell carcinoma;A nyelocsolaphámrák genetikai és molekuláris háttere és a génterápia lehetoségei

Orvosi Hetilap

Volumn 148, Issue 38, 2007, Pages 1795-1800

  Hagymási, Krisztina ^a,b,c   Tulassay, Zsolt ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Semmelweis Egyetem   (Hungary)

Author keywords

Antisense therapy; Esophageal squamous cell carcinoma; Gene replacement; Gene therapy; Interfering RNAs; Molecular biology

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALDEHYDE DEHYDROGENASE ISOENZYME 2; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ARYLAMINE ACETYLTRANSFERASE; BETA CATENIN; BRCA2 PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE; FAS LIGAND; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); SMALL INTERFERING RNA; SULFOTRANSFERASE; TRANSCRIPTION FACTOR E2F1; VASCULOTROPIN;

ADVANCED CANCER; CANCER GENE THERAPY; CANCER GENETICS; CARCINOGENESIS; ESOPHAGUS CARCINOMA; GENE DIRECTED ENZYME PRODRUG THERAPY; GENETIC POLYMORPHISM; HUMAN; MOLECULAR GENETICS; PROTO ONCOGENE; REVIEW; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 34948862285     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28200     Document Type: Review

References (30)

1. McCabe, M. L., Dlamini, Z.: The molecular mechanisms of oesophageal cancer. Int. Immunophramacol., 2005, 5, 1113-1130.
2. Kuwano, H., Kato, H., Miyazaki, T. és mtsai: Genetic alterations in esophageal cancer. Surg. Today, 2005, 35, 7-18.
3. Elton, E.: Esophageal cancer. Dis. Mon., 2005, 51, 664-684.
4. Roberts-Thomson, I. C., Butler, W. J.: Polymorphism and squamous cell cancer of the esophagus. J. Gastroenterol. Hepatol., 2005, 20, 486-487.
5. von Rahden, B. H. A., Stein, H. S.: Staging and treatment of advanced esophageal cancer. Curr. Op. Gastroenterol., 2005, 21, 472-477.
6. Shimada, H, Takeda, A., Sbiratori, T. és mtsai: Prognostic sigificance of serum thymidine phosphorylase concentration in esophageal squamosous cell carcinoma. Cancer, 2002, 94, 1947-1954.
7. Shimada, H., Ochiai, T.: Gene therapy for esophageal squamous cell carcinoma. In: Gene Therapy, 2007, 250-265.
8. Shimada, H, Takeda, A., Shiratori, T. és mtsai: Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer, 2002, 94, 1947-1954.
9. Halloran, C. M., Ghaneh, P., Neoptolemos, J. P. és mtsa: Gene therapy for pancreatic cancer - current and prospective strategies. Surg. Oncol., 2000, 9, 181-191.
10. Tagawa, M., Kawamura, K., Shimozato, O. és mtsai: Virology- and immunology-based gene therapy for cancer. Cancer Immunol. Immunother., 2006, 55, 1420-1425.
11. Lv, H., Zhang, S., Wang, B. és mtsai: Toxicity of cationic lipids and cationic polymers in gene delivery. J. Controlled Dis., 2006, 114, 100-109.
12. Liu, Y., Miyoshi, H., Nakamura, M.: Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J. Controlled Dis., 2006, 114, 89-99.
13. Park, T G., Jeong, J. H, Kim, S. W.: Current status of polymeric gene delivery systems. Advanced Drug Delivery Sys., 2006, 58, 467-486.
14. Majhen, D., Ambriovi-Ristov, A.: Adenoviral vectors - how to use them in cancer gene therapy. Virus Res., 2006, 119, 121-133.
15. Warrington, K. H., Herzog, R. W.: Treatment of human disease by adeno-associated viral gene transfer. Human Genetics, 2006, 119, 571-603.
16. Young, L. S., Searla, P. F., Onion, D. és mtsa: Viral gene therapy strategies: from basic science to clinical application. J. Pathol., 2006, 208, 299-318.
17. Vassaux, G., Nitcheu, J., Jezzard, S. és mtsa: Bacterial gene therapy strategies. J. Pathol., 2006, 208, 290-298.
18. Kasuya, H., Nomoto, S., Nakao, A.: The potential of gene therapy in the treatment of pancreatic cancer. Drugs of Today, 2002, 38, 457-464.
19. Veeramachaneni, N. K., Kubokura, H., Lin, L. és mtsai: Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells. J. Thorac. Cardiovasc. Surg., 2004, 127, 92-98.
20. Gu, Z. P., Wang, Y. J., Li, J. G. és mtsa: VEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma. W. J. Gastroenterol., 2002, 8, 44-48.
21. Tian, F., Zang, W. D., Hou, W. H. és mtsai: Nuclear factor-KB signaling pathway constitutively acivated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim. Biophys. Sinica, 2006, 38, 318-326.
22. Wang, Y., Zhu, H, Quan, L. és mtsai: Downregulation of survivin by RNAi inhibits the growth of esophageal carcinoma cells. Cancer Biol. Ther., 2005, 4, 974-978.
23. Swisher, S. G., Roth, J. A., Komaki, R. és mtsai: Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN201) and radiation therapy. Clin. Cancer Res., 2003, 9, 93-101.
24. Oohira, G., Yamada, S., Ochiai, T. és mtsai: Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer. Int. J. Oncol., 2004, 25, 563-569.
25. Tanaka, Y., Fujii, T., Yamana, H. és mtsai: Experimental gene therapy using p21WafI gene for esophageal squamous cell carcinoma by gene gun technology. Int. J. Mol. Med., 204, 14, 545-551.
26. Matsubara, H., Ochiai, T.: Progress of gene therapy for esophageal cancer in Japan. Jap. J. Cancer Chemother., 2003, 30, 944-949.
27. Saegusa, M., Machida, B. D., Okayasu, I.: Possible association among expression of p14(ARF), p16 (INK4a), p21 (WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Cancer, 2001, 92, 1177-1189.
28. Mori, T, Guo, M., Jin, A. és mtsai: Human esophageal cancer cell death mediated by apoptosis-inducing nucleosides from CD57+HLA-DR Bright natural suppressor cell line. Int. J. Oncol., 2001, 19, 1235-1241.
29. Tan, H, Thomas, J., Liu, T. és mtsai: Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable survivin-antagonist. Oncogene, 2006, 25, 6968-6974.
30. Pandya, N. M., Dhalla, N. S., Santani, D. D.: Angiogenesis - a new target for future therapy. Vasc. Pharmacol., 2006, 44, 264-274.